Kinga has been honored with the prestigious Semmelweis University 2024 Most Innovative PhD Award, recognizing her dedication, persistence, and groundbreaking contributions. This award underscores the profound sense of accomplishment that comes from creating valuable advancements in the preclinical trial field, with meaningful translations into clinical applications.
The project perfectly aligns with Kinga’s passion for drug development and her pursuit of new pharmaceuticals to treat incurable diseases. This award strengthens our commitment to advancing this vital research.
This moment is not only filled with pure joy and pride but also bursting with excitement for the future!
